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Poly Implant Prothèse (PIP) was a company that manufactured substandard 
breast implants using cheaper non-medical grade silicon.  Around 40,000 women 
in the UK are thought to have PIP implants inserted(1).  The advice for Women in 
Wales is: seek clinical advice prior to requesting routine removal.  If there is 
clinical need, the National Health Service (NHS) in Wales funds removal and 
replacement of PIP breast implants inserted privately.  This is in contrast to NHS 
in England where only PIP implants placed on the NHS are replaced. 
 
The Department of Health estimates the rate of implant rupture or significant 
silicone bleed for PIP implants could rising to 15-30% after 10 years; whilst 
other brands demonstrate rupture rates of 10-14% after 10 years. Therefore, 
making this an important issue to address in terms of outcomes, implant 
longevity and health economics.  We present the largest heterogenous (private 
and public health services) experience case series of PIP breast implants to date. 
 
 
Patients & Methods 
We performed a prospective cohort study of all Welsh patients requesting 
assessment of their PIP breast implants between April 2012 and July 2015.  
 
All patients suspected of rupture were offered an ultra-sound scan.  All patients 
with viable concerns of any nature were offered implant removal and 
replacement.  Implant removal +/- replacement was conducted under general 
anaesthetic by a consultant plastic surgeon.  Rupture was defined as a break in 
the continuity of the implant shell and the presence of implant rupture was 
documented by the operating surgeon.  PIP implants were replaced with the 
same volume Mentor® MemoryGel® implant. 
 
Binary Logistic Regression analysis was used to determine if 
symptoms/concerns or rupture was related to patient age, implant size and time 
to rupture.   
 
 
Page 2 of 5
Results 
646 patients were referred, of which 514 patients attended clinic (80%).  The 
mean implant size was 330cc (Mode 270cc). 
 
Implant rupture was clinically suspected in 46 cases, no scan was requested and 
surgery was expedited.  Of these patients 14 (30%) had a confirmed rupture at 
surgery.  Where there was less clinical suspicion of a rupture, patients were 
scanned (n=141).  105 underwent Ultrasound (US) scan, 20 MRI, 16 US & MRI.  
After a scan 80 patients proceeded to have surgical intervention, 49 were 
discharged, 12 elsewhere.  
 
368 (72%) patients had removal of implants, all but two patients having them 
exchanged (99.5%).  90 patients had ruptures confirmed (18%) with two 
bilateral.  33 of these were suspected clinically, 28 were picked up by US and 29 
were incidental findings (See Image 1). 
 
There was no statistical correlation (Odds Ratio (95% Confidence interval) 
between implant rupture and patient age (P=0.94), size of implant (1.0016 
(0.976-1.027)), and time to implantation to rupture (1.0246 (0.926 – 1.133)). 
 
Discussion 
The rupture rate in this series of PIP implants is 18% (90/514) per patient or 
9% (92/1028) per implant.  Table 1 extrapolates the published data to give 
rupture rate per implant and per patient (assuming one rupture per patient).   
There is an overall rupture rate of 12.2% (661/ 5410) per implant and 20% 
(636/3165) per patient.  These studies measure rupture rates over variable time 
frames and rely on differing methods to diagnose implant rupture (US, MRI & 
implant removal).  An 11 year rupture rate of 8% using Inamed (Allergan 
Limited, Marlow, UK)  breast implants in 199 implants (2) and  11.8% using  
Siltex gel implants (Mentor Medical Systems, Santa Barbara, California) by 13 
years in 298 implants(3).  Both studies diagnosed rupture using MRI.  It is clear 
from these studies that the PIP implants have a similar implant rupture rate 
(12.2% in our combined series) in half the time. 
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 Our results show a similar rupture rate compared to other studies in the 
literature, although a slightly lower rate of the combined series.  Our rupture rate 
is based on inspection of the implant at explantation, whereas other studies rely 
on imaging to detect rupture rate.  To some extent this may account for our 
slightly lower rupture rate.   We found no correlation with patient age, implant 
size, length of implantation time and rupture.  This supports the recent paper by 
Leckenby et al. which showed that implant size is not related to the prevalence of 
implant rupture (4). 
 
Validated data on costs to the NHS for removal +/- replacement is scarce in the 
literature.  A clinical assessment and ultrasound scan costing £300 and implant 
removal £1200 - £1250 .  Additional costs arise from patient follow up and 
implant replacement.  
 
 
Conclusion 
The experience of PIP implants in a heterogeneous population in Wales, is 
similar to other studies with regards to overall rupture rate. Our data indicates 
that the rupture rate is independent of implant size, patient age and length 
of time from insertion.  Our experience of PIP implants raise important questions 
on quality control of medical devises and strongly supports the recent 
introduction of a national breast implant registry in the U.K.  (5).   
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Image 1 – Illustration of clinical outcome 
 
 
 
Table 1 – Summary of papers measuring at PIP implant ruptured  
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